Sofiadis Anastasios, Tani Edneia, Foukakis Theodoros, Kjellman Petra, Skoog Lambert, Höög Anders, Wallin Göran, Zedenius Jan, Larsson Catharina
Karolinska University Hospital (Solna), SE-171 76, Stockholm, Sweden.
Int J Oncol. 2009 Aug;35(2):369-74.
Fine needle aspiration biopsy (FNAB) is the preferred technique for the initial diagnostic evaluation of thyroid lesions, which nevertheless poses a diagnostic challenge for all clinicians involved. The latter necessitates the use of molecular markers on thyroid cytology. MIB-1 is a molecular marker already used in the cytological evaluation of various tumors. In this study, we assessed whether MIB-1 proliferation index adds diagnostic information to the conventional cytological analysis of thyroid nodules and prognostic information in thyroid cancers. MIB-1 index for various thyroid lesions was retrospectively reviewed in a series of 504 patients. Furthermore, the prognostic value of MIB-1 index was investigated for 183 of the patients with papillary thyroid cancer (PTC). MIB-1 index was significantly higher in anaplastic thyroid cancer (ATC) compared to other tumor types (p<0.01). No significant difference in MIB-1 index was observed between thyroid adenomas and follicular carcinomas. In PTC, MIB-1 index equal to or >4% was found to be an independent factor significantly associated with higher risk of distant metastasis and disease-related mortality (p<0.05). Conclusively, this study shows that preoperative MIB-1 index assessment in FNAB of thyroid nodules offers little diagnostic information as far as follicular tumors are concerned. In cases of PTC, though, MIB-1 may serve as a prognostic indicator of disease spreading and poor survival and hence influence the planning of the overall treatment scheme.
细针穿刺活检(FNAB)是甲状腺病变初始诊断评估的首选技术,然而,这对所有参与的临床医生来说都是一个诊断挑战。后者需要在甲状腺细胞学检查中使用分子标志物。MIB-1是一种已用于各种肿瘤细胞学评估的分子标志物。在本研究中,我们评估了MIB-1增殖指数是否能为甲状腺结节的传统细胞学分析增加诊断信息以及为甲状腺癌提供预后信息。回顾性分析了504例患者中各种甲状腺病变的MIB-1指数。此外,还对183例甲状腺乳头状癌(PTC)患者的MIB-1指数的预后价值进行了研究。与其他肿瘤类型相比,间变性甲状腺癌(ATC)的MIB-1指数显著更高(p<0.01)。甲状腺腺瘤和滤泡癌之间的MIB-1指数未观察到显著差异。在PTC中,发现MIB-1指数等于或>4%是与远处转移和疾病相关死亡率较高风险显著相关的独立因素(p<0.05)。总之,本研究表明,就滤泡性肿瘤而言,甲状腺结节FNAB术前MIB-1指数评估几乎不提供诊断信息。然而,在PTC病例中,MIB-1可作为疾病扩散和预后不良的预后指标,从而影响整体治疗方案的规划。